Vaxart, Inc. Recorded Big Gain
Wed, Feb 26, 2020 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) soared at $1.65, representing a gain of 36.4%. The stock appeared on our News Catalysts scanner on Tue 18 Feb 20 at 11:44 AM in the 'BIOTECH' category. From Tue 04 Feb 20, the stock recorded 42.86% Up Days and 40.00% Green Days
The stock spiked on Mon 03 Feb 20 at $1.83 with a volume of 78M+, and its share price has been moving sideways in recent weeks.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 122.55%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 106.26%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 60.95%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 48.68%
- Vaxart, Inc. (VXRT:NASDAQ), 36.36%
- Tarena International, Inc. (TEDU:NASDAQ), 35.46%
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 27.54%
- Lianluo Smart Limited (LLIT:NASDAQ), 25.66%
- Remark Holdings, Inc. (MARK:NASDAQ), 24.14%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 23.9%